Saturday, November 23, 2024
HomeTagsPharmAbcine

PharmAbcine

PharmAbcine Announces First Patient Enrolled and Dosed in the Phase II Clinical Trial for the Treatment of mTNBC

PharmAbcine Inc., a clinical-stage biotech company focusing on the development of next generation antibody therapeutics, announced it has dosed the first patient in its...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics